The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Branched Chain Amino Acids (BCAAs)-Global Market Insights and Sales Trends 2025

Branched Chain Amino Acids (BCAAs)-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1833129

No of Pages : 102

Synopsis
Branched chain amino acids (BCAA)-leucine, isoleucine and valine are essential amino acids which are metabolized directly in muscles and offer energy fuel to performance of the work. There is lot of evidences supporting the positive effect of BCAA supplementation on muscle growth. The main importance is attached particularly to leucine.
The global Branched Chain Amino Acids (BCAAs) market size is expected to reach US$ 313.4 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Branched Chain Amino Acids (BCAAs) in various end use industries. The expanding demands from the Food & Beverages, Animal Feed, Pharmaceuticals and Cosmetics, are propelling Branched Chain Amino Acids (BCAAs) market. L-Leucine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the L-Isoleucine segment is estimated at % CAGR for the next seven-year period.
Commercially, Classification of BCAA is usually based on the ratio of Leucine, Isoleucine and Valine. the most common type of BCAA is composed of Leucine, Isoleucine and Valine with ratio at 2:1:1. The 2:1:1 BCAA takes 87% share of global market. Others include 4:1:1, 8:1:1 etc. Application of BCAA can be broadly categized as Sports Nutrition, Pharmaceutical and Others. Sports Nutrition is the major application of BCAA, with market share of 93% in terms of consumption volume.
At present, the BCAA production market concentrates in USA, Europe, China, Japan. China is the largest production country of BCAA in the world in the past few years and it will keep the same position in the next few years. The China market took up about 34% the global market, followed by Japan (25%). In contrast to the production scenario, the consumption of BCAA is concentrated in USA and Europe, which combinedly takes market share of 57%.
Ajinomoto, Kyowa Hakko, Evonik, Fufeng Group and Luzhou are the key suppliers in the global L-valine market. Top five take up about 73% of the global production market. And the production of Ajinomoto occupied about 37%, which supplies BCAA supplement raw material to dozens of companies in USA and Europe.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Branched Chain Amino Acids (BCAAs), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Branched Chain Amino Acids (BCAAs) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Branched Chain Amino Acids (BCAAs) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Branched Chain Amino Acids (BCAAs) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Branched Chain Amino Acids (BCAAs) covered in this report include Amino GmbH (Germany), Nippon Rika Co., Ltd. (Japan), Kyowa Hakko Bio Co., Ltd. (Japan), Fufeng Group Company Limited (China), Ajinomoto Co., Inc. (Japan)s, CJ CheilJedang Corporation (South Korea), Evonik Industries AG (Germany), Meihua Holdings Group Co., Ltd. (China) and Shantou Jiahe Biological Technology Co., Ltd. (China), etc.
The global Branched Chain Amino Acids (BCAAs) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amino GmbH (Germany)
Nippon Rika Co., Ltd. (Japan)
Kyowa Hakko Bio Co., Ltd. (Japan)
Fufeng Group Company Limited (China)
Ajinomoto Co., Inc. (Japan)s
CJ CheilJedang Corporation (South Korea)
Evonik Industries AG (Germany)
Meihua Holdings Group Co., Ltd. (China)
Shantou Jiahe Biological Technology Co., Ltd. (China)
Daesang Corporation (South Korea)
Taj Agro Products (India)
Nutra Green (U.S.)
Global Branched Chain Amino Acids (BCAAs) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Branched Chain Amino Acids (BCAAs) market, Segment by Type:
L-Leucine
L-Isoleucine
L-Valine
Global Branched Chain Amino Acids (BCAAs) market, by Application
Food & Beverages
Animal Feed
Pharmaceuticals
Cosmetics
Personal Care
Sports Nutrition & Fitness
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Branched Chain Amino Acids (BCAAs) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Branched Chain Amino Acids (BCAAs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Branched Chain Amino Acids (BCAAs) Market Overview
1.1 Branched Chain Amino Acids (BCAAs) Product Overview
1.2 Branched Chain Amino Acids (BCAAs) Market Segment by Type
1.2.1 L-Leucine
1.2.2 L-Isoleucine
1.2.3 L-Valine
1.3 Global Branched Chain Amino Acids (BCAAs) Market Size by Type
1.3.1 Global Branched Chain Amino Acids (BCAAs) Market Size Overview by Type (2018-2029)
1.3.2 Global Branched Chain Amino Acids (BCAAs) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Branched Chain Amino Acids (BCAAs) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Branched Chain Amino Acids (BCAAs) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Branched Chain Amino Acids (BCAAs) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Branched Chain Amino Acids (BCAAs) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Branched Chain Amino Acids (BCAAs) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Branched Chain Amino Acids (BCAAs) Sales Breakdown by Type (2018-2023)
2 Global Branched Chain Amino Acids (BCAAs) Market Competition by Company
2.1 Global Top Players by Branched Chain Amino Acids (BCAAs) Sales (2018-2023)
2.2 Global Top Players by Branched Chain Amino Acids (BCAAs) Revenue (2018-2023)
2.3 Global Top Players by Branched Chain Amino Acids (BCAAs) Price (2018-2023)
2.4 Global Top Manufacturers Branched Chain Amino Acids (BCAAs) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Branched Chain Amino Acids (BCAAs) Market Competitive Situation and Trends
2.5.1 Branched Chain Amino Acids (BCAAs) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Branched Chain Amino Acids (BCAAs) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Branched Chain Amino Acids (BCAAs) as of 2022)
2.7 Date of Key Manufacturers Enter into Branched Chain Amino Acids (BCAAs) Market
2.8 Key Manufacturers Branched Chain Amino Acids (BCAAs) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Branched Chain Amino Acids (BCAAs) Status and Outlook by Region
3.1 Global Branched Chain Amino Acids (BCAAs) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Branched Chain Amino Acids (BCAAs) Historic Market Size by Region
3.2.1 Global Branched Chain Amino Acids (BCAAs) Sales in Volume by Region (2018-2023)
3.2.2 Global Branched Chain Amino Acids (BCAAs) Sales in Value by Region (2018-2023)
3.2.3 Global Branched Chain Amino Acids (BCAAs) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Branched Chain Amino Acids (BCAAs) Forecasted Market Size by Region
3.3.1 Global Branched Chain Amino Acids (BCAAs) Sales in Volume by Region (2024-2029)
3.3.2 Global Branched Chain Amino Acids (BCAAs) Sales in Value by Region (2024-2029)
3.3.3 Global Branched Chain Amino Acids (BCAAs) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Branched Chain Amino Acids (BCAAs) by Application
4.1 Branched Chain Amino Acids (BCAAs) Market Segment by Application
4.1.1 Food & Beverages
4.1.2 Animal Feed
4.1.3 Pharmaceuticals
4.1.4 Cosmetics
4.1.5 Personal Care
4.1.6 Sports Nutrition & Fitness
4.1.7 Others
4.2 Global Branched Chain Amino Acids (BCAAs) Market Size by Application
4.2.1 Global Branched Chain Amino Acids (BCAAs) Market Size Overview by Application (2018-2029)
4.2.2 Global Branched Chain Amino Acids (BCAAs) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Branched Chain Amino Acids (BCAAs) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Branched Chain Amino Acids (BCAAs) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Branched Chain Amino Acids (BCAAs) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Branched Chain Amino Acids (BCAAs) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Branched Chain Amino Acids (BCAAs) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Branched Chain Amino Acids (BCAAs) Sales Breakdown by Application (2018-2023)
5 North America Branched Chain Amino Acids (BCAAs) by Country
5.1 North America Branched Chain Amino Acids (BCAAs) Historic Market Size by Country
5.1.1 North America Branched Chain Amino Acids (BCAAs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Branched Chain Amino Acids (BCAAs) Sales in Volume by Country (2018-2023)
5.1.3 North America Branched Chain Amino Acids (BCAAs) Sales in Value by Country (2018-2023)
5.2 North America Branched Chain Amino Acids (BCAAs) Forecasted Market Size by Country
5.2.1 North America Branched Chain Amino Acids (BCAAs) Sales in Volume by Country (2024-2029)
5.2.2 North America Branched Chain Amino Acids (BCAAs) Sales in Value by Country (2024-2029)
6 Europe Branched Chain Amino Acids (BCAAs) by Country
6.1 Europe Branched Chain Amino Acids (BCAAs) Historic Market Size by Country
6.1.1 Europe Branched Chain Amino Acids (BCAAs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Branched Chain Amino Acids (BCAAs) Sales in Volume by Country (2018-2023)
6.1.3 Europe Branched Chain Amino Acids (BCAAs) Sales in Value by Country (2018-2023)
6.2 Europe Branched Chain Amino Acids (BCAAs) Forecasted Market Size by Country
6.2.1 Europe Branched Chain Amino Acids (BCAAs) Sales in Volume by Country (2024-2029)
6.2.2 Europe Branched Chain Amino Acids (BCAAs) Sales in Value by Country (2024-2029)
7 Asia-Pacific Branched Chain Amino Acids (BCAAs) by Region
7.1 Asia-Pacific Branched Chain Amino Acids (BCAAs) Historic Market Size by Region
7.1.1 Asia-Pacific Branched Chain Amino Acids (BCAAs) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Branched Chain Amino Acids (BCAAs) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Branched Chain Amino Acids (BCAAs) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Branched Chain Amino Acids (BCAAs) Forecasted Market Size by Region
7.2.1 Asia-Pacific Branched Chain Amino Acids (BCAAs) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Branched Chain Amino Acids (BCAAs) Sales in Value by Region (2024-2029)
8 Latin America Branched Chain Amino Acids (BCAAs) by Country
8.1 Latin America Branched Chain Amino Acids (BCAAs) Historic Market Size by Country
8.1.1 Latin America Branched Chain Amino Acids (BCAAs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Branched Chain Amino Acids (BCAAs) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Branched Chain Amino Acids (BCAAs) Sales in Value by Country (2018-2023)
8.2 Latin America Branched Chain Amino Acids (BCAAs) Forecasted Market Size by Country
8.2.1 Latin America Branched Chain Amino Acids (BCAAs) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Branched Chain Amino Acids (BCAAs) Sales in Value by Country (2024-2029)
9 Middle East and Africa Branched Chain Amino Acids (BCAAs) by Country
9.1 Middle East and Africa Branched Chain Amino Acids (BCAAs) Historic Market Size by Country
9.1.1 Middle East and Africa Branched Chain Amino Acids (BCAAs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Branched Chain Amino Acids (BCAAs) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Branched Chain Amino Acids (BCAAs) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Branched Chain Amino Acids (BCAAs) Forecasted Market Size by Country
9.2.1 Middle East and Africa Branched Chain Amino Acids (BCAAs) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Branched Chain Amino Acids (BCAAs) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Amino GmbH (Germany)
10.1.1 Amino GmbH (Germany) Company Information
10.1.2 Amino GmbH (Germany) Introduction and Business Overview
10.1.3 Amino GmbH (Germany) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Amino GmbH (Germany) Branched Chain Amino Acids (BCAAs) Products Offered
10.1.5 Amino GmbH (Germany) Recent Development
10.2 Nippon Rika Co., Ltd. (Japan)
10.2.1 Nippon Rika Co., Ltd. (Japan) Company Information
10.2.2 Nippon Rika Co., Ltd. (Japan) Introduction and Business Overview
10.2.3 Nippon Rika Co., Ltd. (Japan) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Nippon Rika Co., Ltd. (Japan) Branched Chain Amino Acids (BCAAs) Products Offered
10.2.5 Nippon Rika Co., Ltd. (Japan) Recent Development
10.3 Kyowa Hakko Bio Co., Ltd. (Japan)
10.3.1 Kyowa Hakko Bio Co., Ltd. (Japan) Company Information
10.3.2 Kyowa Hakko Bio Co., Ltd. (Japan) Introduction and Business Overview
10.3.3 Kyowa Hakko Bio Co., Ltd. (Japan) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Kyowa Hakko Bio Co., Ltd. (Japan) Branched Chain Amino Acids (BCAAs) Products Offered
10.3.5 Kyowa Hakko Bio Co., Ltd. (Japan) Recent Development
10.4 Fufeng Group Company Limited (China)
10.4.1 Fufeng Group Company Limited (China) Company Information
10.4.2 Fufeng Group Company Limited (China) Introduction and Business Overview
10.4.3 Fufeng Group Company Limited (China) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Fufeng Group Company Limited (China) Branched Chain Amino Acids (BCAAs) Products Offered
10.4.5 Fufeng Group Company Limited (China) Recent Development
10.5 Ajinomoto Co., Inc. (Japan)s
10.5.1 Ajinomoto Co., Inc. (Japan)s Company Information
10.5.2 Ajinomoto Co., Inc. (Japan)s Introduction and Business Overview
10.5.3 Ajinomoto Co., Inc. (Japan)s Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ajinomoto Co., Inc. (Japan)s Branched Chain Amino Acids (BCAAs) Products Offered
10.5.5 Ajinomoto Co., Inc. (Japan)s Recent Development
10.6 CJ CheilJedang Corporation (South Korea)
10.6.1 CJ CheilJedang Corporation (South Korea) Company Information
10.6.2 CJ CheilJedang Corporation (South Korea) Introduction and Business Overview
10.6.3 CJ CheilJedang Corporation (South Korea) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 CJ CheilJedang Corporation (South Korea) Branched Chain Amino Acids (BCAAs) Products Offered
10.6.5 CJ CheilJedang Corporation (South Korea) Recent Development
10.7 Evonik Industries AG (Germany)
10.7.1 Evonik Industries AG (Germany) Company Information
10.7.2 Evonik Industries AG (Germany) Introduction and Business Overview
10.7.3 Evonik Industries AG (Germany) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Evonik Industries AG (Germany) Branched Chain Amino Acids (BCAAs) Products Offered
10.7.5 Evonik Industries AG (Germany) Recent Development
10.8 Meihua Holdings Group Co., Ltd. (China)
10.8.1 Meihua Holdings Group Co., Ltd. (China) Company Information
10.8.2 Meihua Holdings Group Co., Ltd. (China) Introduction and Business Overview
10.8.3 Meihua Holdings Group Co., Ltd. (China) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Meihua Holdings Group Co., Ltd. (China) Branched Chain Amino Acids (BCAAs) Products Offered
10.8.5 Meihua Holdings Group Co., Ltd. (China) Recent Development
10.9 Shantou Jiahe Biological Technology Co., Ltd. (China)
10.9.1 Shantou Jiahe Biological Technology Co., Ltd. (China) Company Information
10.9.2 Shantou Jiahe Biological Technology Co., Ltd. (China) Introduction and Business Overview
10.9.3 Shantou Jiahe Biological Technology Co., Ltd. (China) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Shantou Jiahe Biological Technology Co., Ltd. (China) Branched Chain Amino Acids (BCAAs) Products Offered
10.9.5 Shantou Jiahe Biological Technology Co., Ltd. (China) Recent Development
10.10 Daesang Corporation (South Korea)
10.10.1 Daesang Corporation (South Korea) Company Information
10.10.2 Daesang Corporation (South Korea) Introduction and Business Overview
10.10.3 Daesang Corporation (South Korea) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Daesang Corporation (South Korea) Branched Chain Amino Acids (BCAAs) Products Offered
10.10.5 Daesang Corporation (South Korea) Recent Development
10.11 Taj Agro Products (India)
10.11.1 Taj Agro Products (India) Company Information
10.11.2 Taj Agro Products (India) Introduction and Business Overview
10.11.3 Taj Agro Products (India) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Taj Agro Products (India) Branched Chain Amino Acids (BCAAs) Products Offered
10.11.5 Taj Agro Products (India) Recent Development
10.12 Nutra Green (U.S.)
10.12.1 Nutra Green (U.S.) Company Information
10.12.2 Nutra Green (U.S.) Introduction and Business Overview
10.12.3 Nutra Green (U.S.) Branched Chain Amino Acids (BCAAs) Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Nutra Green (U.S.) Branched Chain Amino Acids (BCAAs) Products Offered
10.12.5 Nutra Green (U.S.) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Branched Chain Amino Acids (BCAAs) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Branched Chain Amino Acids (BCAAs) Industrial Chain Analysis
11.4 Branched Chain Amino Acids (BCAAs) Market Dynamics
11.4.1 Branched Chain Amino Acids (BCAAs) Industry Trends
11.4.2 Branched Chain Amino Acids (BCAAs) Market Drivers
11.4.3 Branched Chain Amino Acids (BCAAs) Market Challenges
11.4.4 Branched Chain Amino Acids (BCAAs) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Branched Chain Amino Acids (BCAAs) Distributors
12.3 Branched Chain Amino Acids (BCAAs) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’